Recombinant Human Luteinizing Hormone Is as Effective as, But Safer Than, Urinary Human Chorionic Gonadotropin in Inducing Final Follicular Maturation and Ovulation in in Vitro Fertilization Procedures: Results of a Multicenter Double-Blind Study*
暂无分享,去创建一个
[1] A. Munafo,et al. Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone. , 1998, Fertility and sterility.
[2] A. Munafo,et al. Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone. , 1998, Fertility and sterility.
[3] A. Munafo,et al. Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay. , 1998, Fertility and sterility.
[4] T. E. R. H. L. S. Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group. , 1998, The Journal of clinical endocrinology and metabolism.
[5] E. Loumaye,et al. Recombinant human luteinising hormone to mimic mid-cycle LH surge , 1996, The Lancet.
[6] Z. Shoham,et al. Human chorionic gonadotropin: pharmacokinetics of subcutaneous administration. , 1996, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[7] Z. Shoham,et al. The luteinizing hormone surge--the final stage in ovulation induction: modern aspects of ovulation triggering. , 1995, Fertility and sterility.
[8] G. Zanolo,et al. Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone. , 1995, The Journal of clinical endocrinology and metabolism.
[9] R. Campbell,et al. Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians. , 1995, Human reproduction update.
[10] D. Wolf,et al. Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge. , 1994, The Journal of clinical endocrinology and metabolism.
[11] M. Soules,et al. Onset and characteristics of the midcycle surge in bioactive and immunoactive luteinizing hormone secretion in normal women: influence of physiological variations in periovulatory ovarian steroid hormone secretion. , 1992, The Journal of clinical endocrinology and metabolism.
[12] V. Wiwanitkit,et al. Ovarian hyperstimulation syndrome , 1991, The Lancet.
[13] W. Shen,et al. Disappearance of exogenously administered human chorionic gonadotropin. , 1989, Fertility and sterility.
[14] R. Frydman,et al. Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation , 1988, Fertility and sterility.
[15] A. Golan,et al. Ovarian hyperstimulation syndrome following D-Trp-6 luteinizing hormone-releasing hormone microcapsules and menotropin for in vitro fertilization. , 1988, Fertility and sterility.
[16] P. Devroey,et al. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. , 1988, Human reproduction.
[17] E. Diczfalusy,et al. Clinical-pharmacological studies on human menopausal gonadotrophin. , 1988, Human reproduction.
[18] F. Okonofua,et al. The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program. , 1987, Fertility and sterility.
[19] C. O'neill,et al. Failure of implantation in human in vitro fertilization and embryo transfer patients: The effects of altered progesterone/ estrogen ratios in humans and mice , 1987, Fertility and sterility.
[20] B. Little,et al. Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man. , 1968, The Journal of clinical endocrinology and metabolism.